HALOPERIDOL SOPHARMA

Medicinal product

(Invented) name

HALOPERIDOL SOPHARMA

Active substance (s)

Haloperidolis

Strength

5 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N05AD01, Haloperidol

Marketing authorisation holder

UAB TBS Pharma, Lietuva

Date of authorisation

2022-09-20

Date of renewal

Documents

1730-001-002_HALOPERIDOL SOPHARMA 5mg_ml injekcinis tirpalas PZPL_2022-09-19.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

1 ml tirpalo yra	1 ml
Haloperidolis	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
109452	95558	1095558	ampulė	1 ml N10	ASPĮ	Receptinis	LT/L/22/1730/001	Netiekiama	-	-	No	-	-	Download
109453	95559	1095559	ampulė	1 ml N100	ASPĮ	Receptinis	LT/L/22/1730/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2022-09-20	Registruotas